175

REFERENCES

1. Aevarsson, O. and Skoog, I. “A longitudinal population study of

the minimental state examination in the very old: relation to

dementia and education”, Dement Geriatr Cogn Disord, Vol. 11,

pp. 166-75, 2000.

2. Albert, M.S. and Moss, M.B. “Geriatric Nemopsychology”,

Guilford Press, New York, pp. 33-56, 1988.

3. Alexopoulos, P., Grimmer, T., Perneczky, R., Domes, G. and

Kurz, A. “Progression to dementia in clinical subtypes of mild

cognitive impairment”, Dement Geriatr Cogn Disord, Vol. 22,

No.1, pp. 27-34, 2006.

4. Andreasen, N., Vanmechelen, E., Vanderstichele, H., Davidsson,

P. and Blennow, K. “Cerebrospinal fluid levels of total-tau,

phospho-tau and A beta 42 predicts development of Alzheimer's

disease in patients with mild cognitive impairment”, Acta Neurol

Scand issue, 179, pp. 47-51, 2003.

5. Anstey, K. and Christensen, H. “Education, activity, health, blood

pressure and apolipoprotein E as predictors of cognitive change

in old age: a review”, Gerontology, Vol. 46, pp. 163-177, 2000.

6. Anthony, J.C., LeResche, L. and Niaz, U. “Limits of the Mini-

Mental State as a screening test for dementia and delirium among

hospital patients”, Psychol Med, Vol. 12, pp. 397-408, 1982.

7. Apter, N.S., Halstead, W.C. and Heimburger, R.F. “Impaired

cerebral functions in essential hypertension”, American Journal

of Psychiatry, Vol. 107, pp. 808-813, 1951.

8. Arvanitakis, Z., Wilson, R.S., Li, Y., Aggarwal, N.T. and

Bennett, D.A. “Diabetes and function indifferent cognitive

systems in older individuals without dementia”, Diabetes Care,

Vol. 29, pp. 560-565, 2006.

176

9. Arvanitakis, Z., Wilson, R.S., Bienias, J.L., Evans, D.A. and

Bennett, D.A. “Diabetes Mellitus and Risk of Alzheimer Disease

and Decline in CognitiveFunction”, Archives of Neurology,

Vol. 61, No. 5, pp. 661-666, 2004.

10. Assisib, M., Alimentib, F., Maceliab, S., Di Pietroab, G.,

Lalloniab, P. and Montera “Diabetes and cognitive function:

preliminary studies”, Archives of Gerontology and Geriatrics,

Vol. 22, No. 1, pp. 229-232, 1996.

11. Backman, L. and MacDonald, S.W.S “Death and cognition

desynthesis and outlook”, Eur Psychol, Vol. 11, No. 44, pp. 224-

235, 2006.

12. Baker, L. and Barcai, A. “Psychosomatic aspects of diabetes

mellitus”, In Modern Trends in Pspchosomntic Medicine (Edited

by 0. W. HILL), Butterworths, London, 1970.

13. Barclay, L.L., Weiss, E.M., Mattis, S., Bond, O. and Blass, J.P.

“Unrecognizedcognitive impairment in cardiac rehabilitation

patients”, Journal of the American Geriatrics Society, Vol. 36,

No. 1, pp. 22-28, 1988.

14. Beasers, B. “Teaching the diabetic patient”, Dioberes, Vol. 5,

pp. 146-149, 1956.

15. Becker, M.H. “Sociobehavioural determinants of compliance”, In

Compliance with Therapeutic Regimens (Edited by D. L. Sacket

and R. B. Haynes), Johns Hopkins Press. London, 1976.

16. Biessels, G.J. “Cerebral complications of diabetes: clinical

findings and pathogenetic mechanisms”, The Netherlands Journal

of Medicine, Vol. 54, No. 2, pp. 35-45, 1999.

17. Blennow, K. “CSF biomarkers for mild cognitive impairment”,

Journal of Internal Medicine, Vol. 256, No. 3, pp. 224-234, 1990.

18. Blennow, K. “Cerebrospinal fluid protein biomarkers for

Alzheimer's disease”, NeuroRx, Vol. 1, No. 2, pp. 213-225, 2004.

19. Blennow, K., Wallin, A., Uhlemann, C. and Gottfries, C. “White-

matter lesions on CT in Alzheimer patients: relation to clinical

177

symptomatology and vascular factors”, Acta Neurol Scand,

Vol. 83, pp. 187-193, 1991.

20. Bloom, A. “Relation of the complications of diabetes to the

clinical state”, Proceedings of Royal Society of Medicine,

Vol. 60, pp. 149-152, 1967.

21. Blotnerh “Attempted suicide with insulin”, American Journal of

Medicinal Science, Vol. 227, pp. 387-390, 1954.

22. Blumenthal, H.T. “The aging-disease dichotomy: true or false?”,

Journals of Gerontology, Medical Sciences, Vol. 58, No. 2,

pp. 138-145, 2003.

23. Bowen, J., Teri, L., Kukull, W., McCormick, W., McCurry, S.M.

and Larson, E.B. “Progression to dementia in patients with

isolated memory loss”, Lancet, Vol. 349, No. 9054, pp. 763-765,

1997.

24. Bradley, C. Psychophysiological aspects of stress in diabetic

patients, Ischemic heart disease patients and healthy subjects,

Unpublished Ph.D. Thesis, University of Nottingham, 1978.

25. Bradley, C. “Life events and the control of diabetes mellitus”,

Journal Psychosom., Vol. 23, pp. 159-162, 1979.

26. Brandt, J., Spencer, M. and Folstein, M. “The Telephone

Interview for Cognitive Status”, Neuropsychiatry Neuropsychol.

Behavioural Neurology, Vol. 1, pp. 111-117, 1988.

27. Brandt, J., Spencer, M. and Folstein, M. “The Telephone

Interview for Cognitive Status”, Neuropsychiatry, Journal of

Psychiatry, Vol. 180, pp. 161 -167, 1983.

28. Breteler, M., Claus, J., Van Duijn, C., Launer, L. and Hofman, A.

“Epidemiology of Alzheimer's disease”, Epidemiol., Vol. 14,

pp. 59-82, 1992.

29. Broadhursat “Applications of the psychology of decisions. In

Theoretical and Experimental Bases of the Behuviour Therapies”

(Edited by M. P. Feldmanand A. Broadhurst), Wiley, London,

1976.

178

30. Brun, A. and Englund, E. “A white matter disorder in dementia of

the Alzheimer type: a pathoanatomical study”, Annuals

Neurology, Vol. 19, pp. 253-262, 1986.

31. Butler, S.M., Ashford, J.W. and Snowdon, D.A. “Age, education,

and changes in the Mini-Mental State Exam scores for older

women: Findings from the Nun Study”, Journal of the American

Geriatrics Society, Vol. 44, No. 6, pp. 675-681, 1996.

32. Caballol, N., Marti, M.J. and Tolosa, E. “Cognitive dysfunction

and dementia in Parkinson disease”, Movement Disorders,

Vol. 22, No. 17, pp. 358-366, 2007.

33. Cacioppo, J.T. and Petty, R.E. “The need for cognition”, Journal

of Personality and Social Psychology, Vol. 42, pp. 116-131,

1982.

34. Cauley, J.A., Dorman, J.S. and Ganguli, M. “Genetic and aging

epidemiology.The merging of two disciplines”, Neurologic

Clinics, Vol. 14, No. 2, pp. 467-475, 1996.

35. Centers for Disease Control and Prevention, Alzheimer's

Association “The Healthy Brain Initiative: a National Public

Health Road Map to Maintaining Cognitive Health”, Alzheimer's

Association, Chicago, IL, 2007.

36. Chamberlain, S.R., Blackwell, A.D., Fineberg, N.A., Robbins,

T.W. and Sahakian, B.J. “The neuropsychology of obsessive

compulsive disorder: the importance of failures in cognitive and

behavioural inhibition as candidate endophenotypic markers”,

Neuroscience and Biobehavioural Reviews, Vol. 29, No. 3,

pp. 399-419, 2005.

37. Chen, P., Ratcliff, G., Belle, S.H., Cauley, J.A., DeKosky, S.T.

and Ganguli, M. “Cognitive tests that best discriminate between

presymptomatic AD and those who remain nondemented”,

Neurology, Vol. 55, No. 12, pp. 1847-1853, 2000.

38. Chitra, V., Venkata K.R.CH.H. Varma, P., Krishna raju, M.V.R.

and Jeya Prakash, K. “Study of Antidiabetic and free radical

scavenging activity of the seed extract of strychnos nuxvomica”,

International Journal of Pharmacy and Pharmaceutical Sciences,

Vol. 2, No. 1, 2010.

179

39. Coffey, C.E., Saxton, J.A., Ratcliff, G., Bryan, R.N. and Lucke,

J.F. “Relation ofeducation to brain size in normal aging:

implications for the reservehypothesis”, Neurology, Vol. 53,

No. 1, pp. 189-196, 1999.

40. Colcombe, S.J., Kramer, A.F., Erickson, K.I., Scalf, P., McAuley,

E. and Cohen, N.J. “Cardiovascular fitness, cortical plasticity,

and aging”, Proceedings of National Academy of Science of the

United States of America, Vol. 101, pp. 3316-3321, 2004.

41. Convit, A., Wolf, O.T., Tarshish, C. and de Leon, M.J. “Reduced

glucosetolerance is associated with poor memory performance

and hippocampalatrophy among normal elderly”, Proceedings of

the National Academy of Sciences of the United States of

America, Vol. 100, No. 4, pp. 2019-2022, 2003.

42. Cossa, F.M., Sala, S.D., Musicco, M., Spinnler, H. and Ubezio,

M.C. “The Milan overall dementia assessment and the mini-

mental state examination compared: an epidemiological

investigation of dementia”, European Journal of Neurolgia,

Vol. 6, pp. 289-294, 1999.

43. Craft, S., Dagogo-Jack, S.E., Wiethop, B.V., Murphy, C., Nevins,

R.T. and Fleischman, S. “Effects of hyperglycemia on memory

and hormone levels in dementia of the Alzheimer type: a

longitudinal study”. Behavioural Neuroscience, Vol. 107, pp.

926-940, 1993.

44. Craft, S., Newcomer, J., Kanne, S., Dagogo-Jack, S., Cryer, P.,

Sheline, Y., Luby, J., Dagogo-Jack, A. and Alderson, A.

“Memory improvement following induced hyperinsulinemia in

Alzheimer's disease”, Neurobiology of Aging, Vol. 17, pp. 123-

130, 1996.

45. Crowell, D. “Personality and physical disease: a test of the

Dunbdr hypothesis applied to diabetes mellitus and rheumatic

fever”, Genetic Psychology Monographs, Vol. 48, No. 1953, pp.

117-153, 1953.

46. Croxson, S.C.M. and Jagger, C. “Diabetes and Cognitive

Impairment - a Community based Study of Elderly Subjects”,

Age and Ageing, Vol. 24, No. 5, pp. 421-424, 1995.

180

47. Crum, R.M., Anthony, J.C. and Bassett, S.S. “Population-based

norms for the Mini-Mental State Examination by age and

educational level”, Journal of American Medical Association,

Vol. 269, pp. 2386-2391, 1993.

48. Cukierman, T., Gerstein, H.C. and Williamson, J.D. “Cognitive

decline and dementia indiabetes-systematic overview of

prospective observational studies”, Diabetologia, Vol. 48,

pp. 2460-2469, 2005.

49. Cunningham, W.R. “Intellectual abilities and age”, Schaie KW,

Ed., Annual Review of Gerontology and Geriatrics, Vol. 7, New

York: Springer, pp. 117-134, 1984.

50. Debling, D., Manfred Amelang, Petra Hasselbach and Til

Sturmer, “Diabetes and cognitive function in a population-based

study of elderly women and men”, Journal of Diabetes and its

Complications, Vol. 20, No. 4, pp. 238-245, July 2006.

51. Diabetes-Atlas, Diabetes Atlas 3, http://www.eatlas.idf.org/

media, 2008.

52. DiMatteo M. Robin, Haskard, B. Kelly and Williams, L. Summer

“Health Beliefs, Disease Severity, and Patient Adherence: A

Meta-Analysis”, Medical Care, Vol. 45, No. 6, pp. 521-528, June

2007.

53. Dunbar-Jacob, J. and Mortimer-Stephens, M.K. “Treatment

adherence in chronic disease”, Journal of Clinical

Epidemiology”, Vol. 54, No. 12, Supplement 1, pp. S57-S60,

December 2001.

54. Dunstan, D.W., Zimmet, P.Z., Welborn, T.A., De Courten, M.P.,

Cameron, A.J. and Sicree, R.A. “The rising prevalence of

diabetes and impairedglucose tolerance: the Australian Diabetes,

Obesity and Lifestyle Study”, Diabetes Care, Vol. 25, No. 5,

pp. 829-834, 2002.

55. Earles, J.L. and Salthouse, T.A. “Interrelations of age, health, and

speed”, Journals of Gerontology: Psychological Sciences,

Vol. 50, No. 1, pp. 33-41, 1995.

181

56. Elias, P.K., Elias, M.F., D'Agostino, R.B., Cupples, L.A., Wilson,

P.W. and Silbershatz, H. “NIDDM and blood pressure as risk

factors for poor cognitive performance”, The Framingham Study.

Diabetes Care, Vol. 20, No. 9, pp. 1388-1395, 1997.

57. Elias, P.K., Elias, M.F., Robbins, M.A. and Budge, M.M. “Blood

pressurerelated cognitive decline: does age make a difference?”

Hypertension, Vol. 44, pp. 631-636, 2004.

58. Elias, M.F., Elias, P.K., Sullivan, L.M., Wolf, P.A. and

Agnostino, R.B.D. “Lower cognitive function in the presence of

obesity and hypertension - The Framingham Heart Study”,

International Journal of Obesity and Relative Metabolic Disorder,

Vol. 27, pp. 260-268, 2003.

59. Etzwiler, D.D. and Robb, J.R. “Evaluation of programmed

education among juvenile diabetics and their families”, Diabetes,

Vol. 21, pp. 967-971, 1972.

60. Etzwiler, D.D. and Sines, L.K. “Juvenile diabetes and its

management: Family, social and academic implications”, Journal

of American Medical Association, Vol. 28, pp. 304-308, 1967.

61. Etzwiler, D.D. “What the juvenile diabetic knows about his

disease”, Prdiurrics, Vol. 29, pp. 135-141, 1962.

62. Fabre, C., Chamari, K., Mucci, P., Masse-Biron, J., Prefaut, C.

“Improvement of cognitive function by mental and/or

individualized aerobic training in healthy elderly subjects”,

International Journal of Sports Medicine, Vol. 23, pp. 415-421,

2002.

63. Fanelli, C., Pampanelli, S., Epifano, L., Rambotti, A.M., Ciofetta,

M. and Modarelli, F. “Relative roles of insulin and

hypoglycaemia on induction of neuroendocrine responses to,

symptoms of and deterioration of cognitive function in

hypoglycaemia in male and female humans”, Diabetologia,

Vol. 37, pp. 797-807, 1994.

64. Ferraro, K.F. “Double jeopardy to health for black older adults?”,

Journal of Gerontology, Vol. 42, No. 5, pp. 528-533.

182

65. Fleg, J.L. “Alterations in cardiovascular structure and function

with advancing age”, American Journal of Cardiology, Vol. 57,

pp. 33-44, 1986.

66. Folstein, M.F., Folstein, S.E. and Mc Hugh, P.R. “Mini-mental-

state. A practical method for grading the cognitive state of

patients for clinician”, Journal of Psychiatry, Vol. 12, pp. 189-

198, 1975.

67. Fowlerj, E., Buuzyns, L., Ti, H. and Vani-enbergrh, L. “Effects of

EMG Biofeedback Relaxation Program on the control of

diabetes”, Eiofeed Seorg, Vol. 1, pp. 105- 112, 1976.

68. Fratiglioni, L., Paillard-Borg, S. and Winblad, B. “An active and

socially integrated lifestyle in late life might protect against

dementia”, Lancet Neurolgia, Vol. 3, pp. 343-353, 2004.

69. Gallo, J.J. “Epidemiology of mental disorders in middle age and

late life”, Conceptual issues, Epidemiology, Vol. 17, pp. 83-94,

1995.

70. Gavin, J.R., Alberti, K., Davidson, M.B., DeFronzo, R.A., Drash,

A. and Gabbe, S.G. “Report of the Expert Committee on the

diagnosis and classification of diabetes mellitus”, Diabetes Care,

Vol. 23, pp. S4-S19, 200.

71. Gold, P.E. and Stone, W.S. “Neuroendocrine Effects on Memory

in Aged Rodents and Humans”, Neurobiology of Aging, Vol. 9,

pp. 709-717, 1988.

72. Gold, JoAnn Vogt, Jeremy, L. and Paul, E. “Glucose effects on

memory: Behavioral and pharmacological characteristics”,

Behavioral and Neural Biology, Vol. 46, No. 2, September 1986,

pp. 145-155.

73. Gonder-Fredrik, L., Hall, J.L., Vogt, J., Cox, D.J., Green, J. and

Gold, P.E. “Memory enhancement in elderly humans: effects of

glucose ingestion”, Physiology of Behaviour, Vol. 41, pp. 503-

504, 1987.

74. Goshorn, R.K. “Chronic fatigue syndrome: a review for

clinicians”, Seminar Neurology, Vol. 18, No. 2, pp. 237-242,

1998.

183

75. Graber, A.L., Christman B.G., Alogna, M.T. and Davidson, J.K.

“Evaluation of diabetes patienteducation programmes”, Diuheres,

Vol. 26, pp. 61-64, 1977.

76. Grant, I. and Kyle, G.C., Teichman, A. and Mendels, J. “Recent

life events and diabetes in adults”, P.qvchosom. Medicine,

Vol. 36, pp. 121-128, 1974.

77. Green, R.W. “Self-regulated eating behaviours in a diabetic

mental patient”, Behavioural Therapy, Vol. 9, p. 525, 1978.

78. Grodstein, F., Chen, J., Wilson, R.S. and Manson, J.E. “Type 2

diabetes and cognitive functionin community-dwelling elderly

women”, Diabetes Care, Vol. 24, pp. 1060-1065, 2001.

79. Guarch, J., Marcos, T., Salamero, M. and Blesa, R.

“Neuropsychological markers of dementia in patients with

memory complaints”, International Journal of Geriatry and

Psychiatry, Vol. 19, No. 4, pp. 352-358, 2004.

80. Hale, T.S., Zaidel, E., McGough, J.J., Phillips, J.M. and

McCracken, J.T. “Atypical brain laterality in adults with ADHD

during dichotic listening for emotional intonation and words”,

Neuropsychologia, Vol. 44, No. 6, pp. 896-904, 2006.

81. Hall, K.S., Gao, S., Unverzgat, F.W. and Hendrie, H.C. “Low

education and childhood rural residence: risk for Alzheimer’s

disease in AfricanAmericans”, Neurology, Vol. 54, pp. 95-99,

2000.

82. Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow,

K. and Minthon, L. “Association between CSF biomarkers and

incipient Alzheimer's disease in patients with mild cognitive

impairment: a follow-up study”, Lancet Neurolgia, Vol. 5, No. 3,

pp. 228-234, 2006.

83. Hassing, L.B., Hofer, S.M., Nilsson, S.E., Berg, S., Pedersen,

N.L. and McClearn, G., “Comorbid type 2 diabetes mellitus and

hypertension exacerbatescognitive decline: evidence from a

longitudinal study”, Age and Ageing, Vol. 33, No. 4, pp. 355-

361, 2004.

184

84. Haynes, D.L. and Sackett, R.B. “Compliance with Therapeutic

Regimens”, Johns Hopkins University Press, London, 1976.

85. Hendrie, H.C., Albert, M.S. and Butters, M.A. “The NIH

Cognitive and Emotional Health Project: report of the Critical

Evaluation Study Committee”, Alzheimer's Dementia, Vol. 2,

pp. 12-32, 2006.

86. Henriksson, F., Agardh, C.D., Berne, C., Bolinder, J., Lonnqvist,

F. and Stenstrom, P. “Direct medical costs for patients with type

2 diabetes in Sweden”, Journal of Internal Medicine, Vol. 248,

No. 5, pp. 387-396, 2000.

87. Herukka, S.K., Helisalmi, S., Hallikainen, M., Tervo, S.,

Soininen, H. and Pirttila, T. “CSF Abeta42, Tau and

phosphorylated Tau, APOE epsilon4 allele and MCI type in

progressive MCI”, Neurobiology of Aging, Vol. 28, No. 4,

pp. 507-514, 2007.

88. Hinkle, L.E. and Wolf, S. “Importance of life stress in course and

management of diabetes mellitus”, Journal of American Medical

Association, Vol. 148, pp. 513-520, 1952.

89. Hitt, R., Young-Xu, Y., Silver, M. and Perls, T. “Centenarians:

the older you get, the healthier you have been”, Lancet, Vol. 354,

No. 9179, pp. 652, 1999.

90. Ho, S.C., Woo, J., Sham, A., Chan, S.G. and Yu, A.L.M. “A 3-

year follow-up study of social, lifestyle and health predictors of

cognitive impairment in a Chinese older cohort”, International

Journal of Epidemiology, Vol. 30, pp. 1389-1396, 2001.

91. Hogan, P., Dall, T. and Nikolov, P. “For the American Diabetes

Association. Economic costs of diabetes in the US”, Diabetes

Care, Vol. 2003, No. 26, pp. 917-932, 2002.

92. Horn, J.L. “Intellectual stability concepts”, In: Steinberg, R.J.

(Ed.), Advances in the Psychology of Human Intelligence,

Erlbaum, Hillsdale, NJ, pp. 35-77, 1986.

93. Hsu, H.C. “Does social participation by the elderly reduce

mortality and cognitive impairment”, Aging and Mental Health,

Vol. 11, pp. 699-707, 2007.

185

94. Hulka, B.S., Kupper, L., Cassel, J.C. and Mayo, F. Doctor-patient

communication and outcomes among diabetic patients, Journal of

Community Health, Vol. 1, pp. 15-20, 1975.

95. Hultsch, D.F., Hertzog, C., Small, B.J., McDonald-Miszczak, L.

and Dixon, R.A. “Short-term longitudinal change in cognitive

performance in later life”, Psychology of Aging, Vol. 7, pp. 571-

584, 1992.

96. Ivanoiu, A. and Sindic, C.J. “Cerebrospinal fluid TAU protein

and amyloid beta 42 in mild cognitive impairment: prediction of

progression to Alzheimer's disease and correlation with the

neuropsychological examination”, Neurocase, Vol. 11, No. 1,

pp. 32-39, 2005.

97. Jama Warsama, J., Launer, L.J., Witteman, J.C.M., den Breeijen,

J.H., Breteler, M.M.B., Grobbee, D.E. and Hofman, A. “Dietary

Antioxidants and Cognitive Function in a Population-based

Sample of Older Persons, The Rotterdam Study”, American

Journal of Epidemiology, Vol. 144, No. 3, pp. 275-280, 1996.

98. Janis, I.L. “Stages in the decision making process, In Theories OJ

Coynirice Consistency: A Source Book”, (Edited by R. P.

Arelwnet -11.)R. and McNally, Chicago, 1968.

99. Janis, I.K. and King, B.T. “The influence of role playing on

opinion change”, Journal of Abnormal Psychology, Vol. 49,

pp. 211-218, 1954.

100. Jansen, C.E., Miaskowski, C.A., Dodd, M.J. and Dowling, G.A.

“A meta-analysis of the sensitivity of various neuropsychological

tests used to detect chemotherapy-induced cognitive impairment

in patients with breast cancer”, Oncology and Nursing Forum,

Vol. 34, No. 5, pp. 997-1005, 2007.

101. Janssen, I., Katzmarzyk, P.T. and Ross, R. “Waist circumference

and not bodymass index explains obesity-related health risk”,

American Journal of Clinical Nutrition, Vol. 79, No. 3, pp. 379-

384, 2004.

102. Jasmanda H. Wu, Mary N. Haan, Jersey Liang, P.H., Debashis

Ghosh, Hector M. Gonzalez and William H. Herman, “Impact of

Antidiabetic Medications on Physical and Cognitive Functioning

186

of Older Mexican Americans with Diabetes Mellitus: A

Population-based Cohort Study”, Annals of Epidemiology,

Vol. 13, No. 5, pp. 369-376, May 2003.

103. Jason, L.A., Corradi, K., Torres-Harding, S., Taylor, R.R. and

King, C. “Chronicfatigue syndrome: the need for subtypes”,

Neuropsychological Rev, Vol. 15, No. 1, pp. 29-58, 2005.

104. Joyce, E.M. and Roiser, J.P. “Cognitive heterogeneity in

schizophrenia”, Current Openion on Psychiatry, Vol. 20, No. 3,

pp. 268-272, 2007.

105. Juva, K., Sulkava, R., Erkinjuntti, T., Valvanne, J., Tilvis, R.

“Prevalence of dementia in the city of Helsinki”, Acta Neurol

Scand, Vol. 87, pp. 106-110, 1993.

106. Kaiyala, K.J., Prigeon, R.L., Kahn, S.E., Woods, S.C. and

Schwartz, M.W. “Obesity induced by a high-fat diet is associated

with reduced brain insulin transport in dogs”, Diabetes, Vol. 49,

No. 9, pp. 1525-1533, 2000.

107. Kalmijn, S., Feskens, E.J.M., Launer, L.J., Stijnen, T., Kromhout,

D. “Glucose intolerance, hyperinsulinaemia and cognitive

function in a general population of elderly men”, Diabetologia,

Vol. 38, pp. 1096-1102, 1995.

108. Kalmijn, S., Launer, L.J., Alewijn Ott, A., Witteman, J.C., and

Breteler, M.M. “Dietary fat intake and the risk of incident

dementia in the Rotterdam study”, Annals of Neurology, Vol. 42,

No. 5, pp. 776-782, November 1997.

109. Kang, J.H., Ascherio, A. and Grodstein, F. “Fruit and vegetable

consumption and cognitive decline in aging women”, Anual of

Neurolgia, Vol. 57, pp. 713-720, 2005.

110. Karp, A. “Mental, physical and social components in leisure

activities equally contribute to decrease dementia risk”, Dementia

and Geriatric Cognitive Disorder, Vol. 21, pp. 65-73, 2006.

111. Katzman, I.L. “Education and the prevalence of dementia and

Alzheimer’s disease”, Neurology, Vol. 43, pp. 13-20, 1993.

187

112. Keefe, R.S. and Fenton, W.S. “How should DSM-V criteria for

schizophrenia include cognitive impairment?” Schizophrenia

Bulletin, Vol. 33, No. 4, pp. 912-920, 2007.

113. Kerr, D., Reza, M., Smith, N. and Leatherdale, B.A. “Importance

of insulin in subjective, cognitive, and hormonal responses to

hypoglycemia in patients with IDDM”, Diabetes, Vol. 40,

pp. 1057-1062, 1991.

114. Khaw, K.T., Wareham, N. and Luben, R. “Glycated

haemoglobin, diabetes, and mortality in men in Norfolk cohort of

European Prospective Investigation of Cancer and Nutrition”

(EPIC-Norfolk), British Medical Journal, Vol. 322, pp. 15-18,

2001.

115. Klein, R. “Hyperglycemia and microvascular and macrovascular

disease in diabetes”, Diabetes Care, Vol. 18, No. 2, p. 268, 1995.

116. Kline, M.V. and Linder, M. “Psychodynamic factors in the

experimental investigation of hypnotically induced emotions with

particular reference to blood glucose measurement”,

Psychology, Vol. 71, pp. 21-25, 1969.

117. Knowlesh, C., Guest, G.M., Lampej kesslerm and Skillmant, G.

“The course of juvenile diabetes treated with unmeasured diet”,

Diabetes, Vol. 14, pp. 239-273, 1965.

118. Koch, M.F. and Molnar, G.D. “Psychiatric aspects of unstable

diabetes”, Psychosomatic Medicine, Vol. 36, pp. 57-68, 1974.

119. Koivisto, K., Reinikainen, K., Heninen, T., Vanhanen, M.,

Helkala, E.L., Mykkanen, L., Laakso, M., Pyorala, K. and

Riekkinen, Sr. “Prevalence of age-associated memory impairment

in a randomly selected population from eastern Finland”,

Neurology, Vol. 45, pp. 741-747, 1995.

120. Kramer, A.F., Hahn, S., Cohen, N.J., Banich, M.T., McAuley, E.

and Harrison, C.R. “Ageing, fitness and neurocognitive

function”, Nature, Vol. 400, pp. 418-4199, 1999.

121. Kramer, A.F. and Erickson, K.I. “Effects of physical activity on

cognition, well-being, and brain: human interventions”,

Alzheimer's and Dementia, Vol. 3, pp. 45-51, 2007.

188

122. Laakso, M., Reunanen, A., Klaukka, T., Aromaa, A., Maatela, J.

and Pye, K. “Changes in the prevalence and incidence of diabetes

mellitus in Finnish adults”, 1970-1987, American Journal of

Epidemiology, Vol. 133, pp. 850-857, 1991.

123. Labouvie-Vief, G. “Intelligence and cognition”, In: Birren JE,

Schaie KW, eds. Handbook of the Psychology of Aging, New

York: Van Nostrand Reinhold, pp.500-530, 1985.

124. Langa, K.M., Foster, N. and Larson, E.B. “Mixed dementia:

emerging concepts and therapeutic implications”, Journal of the

American Medical Association, Vol. 292, No. 23, pp. 2901-2908,

2004.

125. Lawrence, A.D. and Sahakian, B.J. “Alzheimer disease, attention

and the cholinergic system”, Alzheimer Disease Associated

Disorder, Vol. 9, No. 2, pp. 43-49, 1995.

126. Leon, G.R. “Current directions in the treatment of obesity”,

Psychological. Bulletin, Vol. 83, pp. 557-578, 1976.

127. Ley, P. and Spelmas, S. “Communicating with the Purienr”,

Staples Press, London, 1967.

128. Ley, P., Bradshah, P.W., Eaves, D. and Walker, C.M. “A method

for increasing patients’ recall of information presented by

doctors”, Psychological Medicine, Vol. 3, pp. 217-220, 1973.

129. Lezak, M. “Neuropsychological Assessment, Oxford University

Press, New York, 1995.

130. Li, G., Sokal, I., Quinn, J.F., Leverenz, J.B., Brodey, M. and

Schellenberg, G.D. “CSF tau/Abeta 42 ratio for increased risk of

mild cognitive impairment: a follow-up study”, Neurology,

Vol. 69, No. 7, pp. 631-639, 2007.

131. Lipson, L.G. “Diabetes in the Elderly - Diagnosis, Pathogenesis,

and Therapy”, American Journal of Medicine, Vol. 80, No.5A,

pp. 10-21, 1986.

189

132. Loo, S.K., Hopfer, C., Teale, P.D. and Reite, M.L. “EEG

correlates of methylphenidate response in ADHD: association

with cognitive and behavioural measures”, Journal of Clinical

Neurophysiology, Vol. 21, No. 6, pp. 457-464, 2004.

133. Luchsinger, J.A., Reitz, C., Patel, B., Tang, M.X., Manly, J.J.

and Mayeux, R. “Relation of diabetes to mild cognitive

impairment”, Archives of Neurolgia, Vol. 64, No. 4, pp. 570-

575, 2007.

134. Manning, C.A., Hall, J.L., and Gold, P.E. “Glucose effects on

memory and other neuropsychological tests in elderly humans”,

Psychological Science, Vol. 1, pp. 307-311, 1990.

135. Martin, F.I.R. and Warne, G.L. “Factors influencing the

prognosis of vascular disease in insulin-deficient diabetics of long

duration”, A seven-year follow-up. Metabolism, Vol. 24, pp. 1-9,

1975.

136. McCall, A.L. “The impact of diabetes on the CNS”, Diabetes,

Vol. 41, pp. 557-570, 1992.

137. McClelland, G.H. and Judd, C.M. “Statistical difficulties of

detecting interactions and moderator effects”, Psychological

Bulletin, Vol. 114, No. 2, pp. 376-390, 1993.

138. McKhann, G., Drachman, D. and Folstein, M., “Clinical

diagnosis of Alzheimer’s disease: report of the NINCDS-

ADRDA Work Group under the auspices of Department of

Health and Human Services Task Force on Alzheimer’s disease”,

Neurology, Vol. 34, pp. 939-944, 1984.

139. Messier, C. “Impact of impaired glucose tolerance and type 2

diabetes on cognitive aging”, Neurobiology of Aging, Vol. 26,

No. 1, pp. 26-30, 2005.

140. Miles, W.R. and Root, H.F. “Psychologic tests applied to diabetic

patients”, Archieves of Internal Medicine, Vol. 30, pp. 767-777,

1922.

190

141. Morris, J.C., Storandt, M., Miller, J.P., McKeel, D.W., Price, J.L.

and Rubin, E.H. “Mild cognitive impairment represents early-

stage Alzheimer disease”, Archieves of Internal Medicine,

Vol. 58, No. 3, pp. 397-405, 2001.

142. Morris, M.C., Evans, D.A. and Tangney, C.C. “Associations of

vegetable and fruit consumption with age-related cognitive

change”, Neurology, Vol. 67, pp. 1370-1376, 2006.

143. Munshi, M., Grande, L., Hayes, M., Ayres, D., Suhl, E.,

Capelson, R., Lin, S., Milberg, W. and Weinger, K. “Cognitive

dysfunction is associated with poor diabetes control in older

adults”, Diabetes Care, Vol. 29, pp. 1794- 1799, 2006.

144. Murray, I. and Wang, I. “A comparison of dbese and non-obese

diabetic subjects”, Diabetes, Vol. 5, pp. 48-52, 1956.

145. Mykken, L., Laakso, M., Uusitupa, M. and Pya, K. “Prevalence

of diabetes and impaired glucose tolerance in elderly subjects and

their association with obesity and family history of diabetes”,

Diabetes Care, Vol. 13, pp. 1099-1105, 1990.

146. Nash, D.T. and Fillit, H. “Cardiovascular disease risk factors and

cognitive impairment”, American Journal of Cardiology, Vol. 97,

pp. 1261-1265, 2006.

147. Oei, Y., Everaerd, W.T., Elzinga, B.M., Van Well, S. and

Bermond, B. “Psychosocial stress impairs working memory at

high loads: An association with cortisol levels and memory

retrieval”, Stress, Vol. 9, No. 3, pp. 133-14, 2006.

148. Ohlsson, L.O., Larsson, B., Eriksson, H., Svdsudd, K., Welin, L.

and Tibblin, G. “Diabetes mellitus in Swedish middle-aged men.

The study of men born in 1913 and 1923”, Diabetologia, Vol. 30,

pp. 386-393, 1987.

149. Okereke MD, Olivia I,Jae H. Kang ScD, Nancy R. Cook ScD, J.

Michael Gaziano MD, JoAnn E. Manson MD, DrPH, Julie E.

Buring ScD, Francine Grodstein ScD, “Type 2 Diabetes Mellitus

and Cognitive Decline in Two Large Cohorts of Community-

Dwelling Older Adults”, Journal of the American Geriatrics

Society, Vol. 56, No. 6, pp. 1028-1036, June 2008.

191

150. Palovick, R.A., Phillips, M.I., Kappy, M.S., and Raizada, M.K.

“Insulin inhibits pyramidal neurons in hippocampal slices”, Brain

Research, Vol. 309, pp. 187-191, 1984.

151. Par, C.R. “Cognitive effects of insulin in the central nervous

system”, Neuroscience and Biobehavioral Reviews, Vol. 25,

No. 4, pp. 311-323, 2001.

152. Perlmutter, M., Adams, C., Berry, J., Kaplan, M., Person, D. and

Verdonik, F. “Aging and memory”, In: Schaie KW, Annual

Review of Gerontology and Geriatrics, New York, Springer,

Vol. 7, pp. 57-92, 1987.

153. Petersen, R.C., Doody, R., Kurz, A., Mohs, R.C., Morris, J.C. and

Rabins, P.V. “Current concepts in mild cognitive impairment”,

Archives of Neurology, Vol. 58, No. 12, pp. 1985-1992, 2001.

154. Petersen, R.C. “Mild cognitive impairment as a diagnostic

entity”, Journal of Internal Medicine, Vol. 256, No. 3, pp. 183-

194, 2004.

155. Petersen, R.C., Smith, G.E., Waring, S.C., Ivnik, R.J., Tangalos,

E.G. and Kokmen, E. “Mild cognitive impairment: clinical

characterization and outcome”, Archives of Neurology, Vol. 56,

No. 3, pp. 303-308, 1999.

156. Petersen, R.C., Smith, G.E., Waring, S.C., Ivnik, R.J., Kokmen,

E. and Tangelos, E.G. “Aging, memory, and mild cognitive

impairment”, Internal Psychogeriatrics, Vol. 9, No. 1, pp. 65-69,

1997.

157. Petersonc, M., Jonesr, L., Dupuis, A., Bernsteinr and O’ Sheam

“Feasibility of tight control of juvenile diabetes through patient

monitored glucose determinations”, Paper presented to the

American Diabetes Association, 1978.

158. Pya, K., Laakso, M. and Uusitupa, M. “Diabetes and

atherosclerosis: an epidemiological view”, Diabetes Metabolic

Review, Vol. 3, No. 2, pp. 464-524, 1987.

192

159. Raichle, M.E., Herscovitch, P., Mintun, M., Martin, W.R. and

Powers, W. “Dynamic measurements in the study of higher

cortical function in humans with positron emission tomography”,

Annual of Neurology, Vol. 15, pp. 48-49, 1984.

160. Ramachandran, A., Snehalatha, C., Kapur, A., Vijay, V., Mohan,

V., Das, A.K., Rao, P.V., Yajnik, C.S., Prasanna Kumar, K.M.

and Jyotsna, D. The Diabetes Epidemiology Study Group in India

(DESI): “High prevalence of diabetes and impaired glucose

tolerance in India: National Urban Diabetes Survey”,

Diabetologia, Vol. 44, pp. 1094-1101, 2001.

161. Reaven, G.M., Thompson, L.W., Nahum, D. and Haskins, E.

“Relationship between hyperglycemia and cognitive function in

older NIDDM patients”, Diabetes Care, Vol. 13, pp. 16-20, 1990.

162. Reichard, Bengt-Yngve Nilsson, and Urban Rosenqvist. “The

Effect of Long-Term Intensified Insulin Treatment on the

Development of Microvascular Complications of Diabetes

Mellitus”, New England Journal of Medicine, Vol. 329, pp. 304-

309, 1993.

163. Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Forstl, H. and

Henn, F. “Cognitive impairment in 873 patients with idiopathic

Parkinson's disease. Results from the German Study on

Epidemiology of Parkinson's Disease with Dementia” (GEPAD),

Journal of Neurolgia, Vol. 255, No. 2, pp. 255-264, 2008.

164. Ritchie, K., Artero, S. and Touchon, J. “Classification criteria for

mild cognitive impairment: a population-based validation study”,

Neurology, Vol. 56, No. 1, pp. 37-42, 2001.

165. Roca, M., Torralva, T., Meli, F., Fiol, M., Calcagno, M.L. and

Carpintiero, S. “Cognitive deficits in multiple sclerosis correlate

with changes in fronto-subcortical tracts”, Multiple Sclerosis,

Vol. 14, No. 3, pp. 364-369, 2008.

166. Rosen, H. and Lidz, T. “Emotional factors in the precipitation of

recurrent diabetic acidosis”, Psychosomatic Medicine, Vol. 11,

pp. 211-215, 1949.

193

167. Ryan, C.M. and Geckle, M.O. “Circumscribed cognitive

dysfunction in middle-aged adults with type 2 diabetes”, Diabetes

Care, Vol. 23, pp. 1486-1493, 2000.

168. Sanders, K., Mills, J., Martin, F.I.R., Horned, J. and De, L.

“Emotional attitudes in adult insulin dependent diabetes”, Journal

of psychosomal Research, Vol. 19, pp. 241-246, 1975.

169. Sanisoglu, S., Cagatay Oktenli, Adnan Hasimi, Mehmet

Yokusoglu and Mehmet Ugurlu “Prevalence of metabolic

syndrome-related disorders in a large adult population in

Turkey”, BMC Public Health, 6:92, doi:10.1186/1471-2458-6-92,

2006.

170. Scarmeas, N. and Stern, Y. “Cognitive reserve and lifestyle”,

Journal of Clinical and Experimental Neuropsychology, Vol. 25,

pp. 625-633, 2003.

171. Schmidtke, K. and Hermeneit, S. “High rate of conversion to

Alzheimer's disease in a cohort of amnestic MCI patients”,

International Psychogeriatrics, Vol. 20, No. 01, pp. 96-108, 2007.

172. Schoonenboom, S.N., Visser, P.J., Mulder, C., Lindeboom, J.,

Van Elk, E.J. and Van Kamp, G.J. “Biomarker profiles and their

relation to clinicalvariables in mild cognitive impairment”,

Neurocase, Vol. 11, No.1, pp. 8-13, 2005.

173. Schuit, A.J., Feskens, E.J., Launer, L.J. and Kromhout, D.

“Physical activity and cognitive decline, the role of the

apolipoprotein e4 allele”, Medicine and Science in Sports and

Exercise, Vol. 33, No. 5, pp. 772-777, 2001.

174. Schulingkamp, R.J., Pagano, T.C., Hung, D. and Raffa, R.B.

“Insulin receptors and insulin action in the brain: review and

clinical implications”, Neuroscience and Biobehavioral Reviews,

Vol. 24, No. 8, pp. 855-872, 2000.

175. Seyfaddini Rostam “Cognitive function in diabetes mellitus

patients”, American Journal of Applied Sciences, Vol. 3, No. 1,

pp. 1682-1684, 2006.

194

176. Shibata, S., Liou, S.Y., Ueki, S. and Oomura, Y. “Inhibitory

action of insulin on suprachiasmatic nucleus neurons in rat

hypothalamic slice preparation”, Physiological Behaviour,

Vol. 36, pp. 79-81, 1985.

177. Simonds, J.F. “Psychiatric status of diabetic youth in good and

poor control”, The International Journal of Psychiatry in

Medicine, Vol. 7, pp. 133-151, 1977.

178. Skyler, J.S. “Diabetic complications: The importance of glucose

control”, Endocrinology and Metabolism Clinics of North

America, Vol. 25, pp. 243-245, 1996.

179. Sloane, P.D., Zimmerman, S. and Suchindran, C. “The public

health impact of Alzheimer's disease, 2000-2050: potential

implication of treatment advances”, Annual Review of Public

Health, Vol. 23, pp. 213-231, 2002.

180. Sowers, J.R., Epstein, M. and Frohlich, E.D. “Diabetes,

Hypertension, and Cardiovascular Disease: An Update”,

Hypertension, Vol. 37, No. 4, pp. 1053-1059, 2001.

181. Spiegel, A.D. “Programmed instructional materials for patient

education”, Journal of Medical Education, Vol. 42, pp. 958-962,

1967.

182. Squire, L.R. and Knowlton, B.J. “Memory, hippocampus, and

brain systems”, In M. S. Gazzaniga (Ed.), the cognitive

neurosciences. Cambridge, MA: MIT Press., pp. 825-837, 1995.

183. Squire, L.R. “Memory and the hippocampus: a synthesis of

findings with rats, monkeys and humans”, Psychological Review,

Vol. 99, No. 2, pp. 195-231, 1992.

184. Stearns, S. “Self-destructive behaviour in young patients with

diabetes mellitus”, Diabetes, Vol. 8, pp. 379-382, 1959.

185. Stern, M.P. Kelly West Lecture, “Primary prevention of typeII

diabetes mellitus”, Diabetes Care, Vol. 14, pp. 399-410, 1991.

186. Stern, M.P. “Diabetes and cardiovascular disease. The common

soil hypothesis”, Diabetes, Vol. 44, pp. 369-374, 1995.

195

187. Stewart, R. and Liolitsa, D. “Type 2 diabetes mellitus, cognitive

impairment and dementia”, Diabetic Medicine, Vol. 16, No. 2,

pp. 93-112, February 1999.

188. Stone, W.S., Walsher, B., Gold, S.D. and Gold, P.E.

“Scopolamine and morphine-induced impairment of spontaneous

alternation performance in mice: reversal with glucose and with

cholinergic and adrenergic agonists”, Behavioral Neuroscience,

Vol. 105, pp. 264-272, 1991.

189. Stone, D.B. “A study of the incidence and causes of poor control

in patients with diabetes mellitus”, American Journal of

Medicinal Science, Vol. 241, pp. 436-441, 1961.

190. Strachan, M.W., Reynolds, R.M., Frier, B.M., Mitchell, R.J. and

Price, J.F. “The relationshipbetween type 2 diabetes and

dementia”, British Medical Bulletin, Vol. 88, No. 1, pp. 131-146,

2008.

191. Strachan, M.W.J., Deary, I.J., Ewing F.M.E. and Frier, B.M. “Is

type II diabetes associated with an increased risk of cognitive

dysfuction?” Diabetes Care, Vol. 20, pp. 438-445, 1997a.

192. Strachan, M.W.J., Frier, B.M. and Deary, I.J. “Cognitive

assessment in diabetes: the need for consensus”, Diabetic

Medicines, Vol. 14, pp. 421-422, 1997b.

193. Sulway, M. “Patient compliance and treatment outcome in

diabetes”, Paper given at King’s College Hospital, London, 30

June, 1977.

194. Swihart, A.A. and Prinzzolo, F.J. “The neuropsychokogy of aging

and dementia: Clinical issues”, Neuropsychological Studies of

Nonfocal Brain Damage, New York, Springer; Vol. 1, pp. 15,

1988.

195. Tabert, M.H., Manly, J.J., Liu, X., Pelton, G.H., Rosenblum, S.

and Jacobs, M. “Neuropsychological prediction of conversion to

Alzheimer disease in patients with mild cognitive impairment”,

Archieves of General Psychiatry, Vol. 63, No. 8, pp. 916-924,

2006.

196

196. Tani, G.S. and Hankin, J.H. “A self-learning, unit for patients

with diabetes”, Journal of American Diet Association, Vol. 4,

No. 58, pp. 331-335, 1971.

197. Teng, E.L. and Chui, H.C. “The Modified Mini-Mental State

(3MS) Examination”, Journal of Clinical Psychiatry, Vol. 48,

pp. 314-318, 1987.

198. Teng, E.L., Hasegawa, K. and Homma, A. “The Cognitive

Abilities Screening Instrument (CASI) : a practical test for cross-

cultural epidemiologic studies of dementia”, Internal

Psychogeriatry, Vol. 6, pp. 45-56, 1994.

199. Thoresenc, E. and Mahoneym, J. “Behavioural Self Control”,

Holt-Rinehart, New York, 1974.

200. Tierney, M.C., Szalai, J.P., Snow, W.G., Fisher, R.H., Nores, A.

and Nadon, G. “Prediction of probable Alzheimer's disease in

memory-impaired patients: A prospective longitudinal study”,

Neurology, Vol. 46, No. 3, pp. 661-665, 1996.

201. Treutingt, F. “The role of emotional factors in the etiology and

course of diabetes mellitus: A review of the recent literature”,

American Journal of Medical Science, Vol. 244, pp. 92-109,

1962.

202. Tuneridger, E. “Sociomedical aspects of diabetes mellitus”,

Lancet, Vol. 2, pp. 893-899, 1953.

203. Unger, J.W., Livingston, J.N. and Moss, A.M. “Insulin receptors

in the centralnervous system: localization, signalling mechanisms

and functional aspects”, Progress in Neurobiology, Vol. 36,

No. 5, pp. 343-362, 1991.

204. Van Duijn, C.M. “Epidemiology of the dementias: recent

developments and new approaches”, Journal Neurology,

Neurosurgery and Psychiatry, Vol. 60, pp. 478-488, 1996.

205. Van Gelder, B.M., Tijhuis, M.A.R., Kalmijn, S., Giampaoli, S.,

Nissinen, A. and Kromhout, D. “Physical activity in relation to

cognitive decline in elderly men: the FINE Study”, Neurology,

Vol. 63, pp. 2316-2321, 2004.

197

206. Vandenbergrh, L., Sussmank, E. and Titus, C.C. “Effects of

hypnotically induced acute emotional stress on carbohydrate and

liquid metabolism in patients with diabetes mellitus”,

Psychosomatic Medicine, Vol. 28, pp. 382-390, 1966.

207. Vogels, R.L., Oosterman, J.M., van Harten, B., Scheltens, P., van

der Flier, W.M. and Schroeder-Tanka, J.M. “Profile of cognitive

impairment in chronic heart failure”, Journal of the American

Geriatrics Society, Vol. 55, No. 11, pp. 1764-1770, 2007.

208. Wahlin, A., Hill, R.D., Winblad, B. and Backman, L. “Effects of

serum vitaminB12 and folate status on episodic memory

performance in very old age: a population-based study”,

Psychology and Aging, Vol. 11, No. 3, pp. 487-496, 1996.

209. Wahlin, A. “Health, disease, and cognitive functioning in old

age”, In R. A. Dixon, L. Backman and Nilsson, L.G. (Eds.), New

frontiers in cognitive aging, Oxford, UK: Oxford University

Press, pp. 279-302, 2004.

210. Waldstein, S.R., Rice, S.C., Thayer, J.F., Najjar, S.S., Scuteri, A.

and Zonderman, A.B. “Pulse pressure and pulse wave velocity

are related to cognitive decline in the Baltimore Longitudinal

Study of Aging”, Hypertension, Vol. 51, pp. 99-104, 2008.

211. Wallum, B.J., Taborsky, G.J., Porte, D., Figlewiczm D.P.,

Jacobson, L. and Beard, J.C. “Cerebrospinal fluid insulin levels

increase during intravenous insulin infusions in man”, Journal of

clinical endocrinology and metabolism, Vol. 64, No. 1, pp. 190-

194, 1987.

212. Watkins, J.D., Robertsd, E., Williamst, F., Martin, D.A. and

Coylev “Observation of medication errors made by diabetic

patients in the home”, Diabetes, Vol. 16, pp. 882-885, 1967a.

213. Watkins, J.D., Williamst, F., Martin, D.A., Hogan, M.D. and

Andersone “A study of diabetic patients at home”, American

Journal of Public Health and Nations Health, Vol. 57, pp. 452-

459, 1967b.

214. Watson, G.S. and Craft, S. “Insulin resistance, inflammation, and

cognition in Alzheimer's Disease: Lessons for multiple sclerosis”,

Journal of the Neurological Sciences, 2006.

198

215. Wenk, G.L. “An hypothesis on the role of glucose in the

mechanism of action of cognitive enhancers”,

Psychopharmacology, Vol. 99, pp. 431-438, 1981.

216. West, K.M. “Diet therapy of diabetes. An analysis of failure”,

Annuals of Internal Medicine, Vol. 79, pp. 425-434, 1973.

217. Weuve, J., Kang, J.H., Manson, J.E., Breteler, M.M.B, Ware, J.H.

and Grodstein, F. “Physical activity, including walking, and

cognitive function in older women”, Journal of American

Medical Association, Vol. 292, pp. 1454-1461, 2004.

218. Williams, G. and Pickup, J.C. Handbook of diabetes (3 ed.),

Malden, MA:Blackwell Publication, 2004.

219. Williamst, F., Martind, A., Hogan, M.D., Watkinsj, F. and Ellis,

E. “The clinical picture of diabetic control, studied in four

settings”, American Journal of Public Health and the Nations

Health, Vol. 57, pp. 441-451, 1967.

220. Wilson, R.S., Schneider, J.A., Boyle, P.A., Arnold, S.E., Tang, Y.

and Bennett, D.A. “Chronic distress and incidence of mild

cognitive impairment”, Neurology, Vol. 68, No. 24, pp. 2085-

2092, 2007.

221. Winblad, B., Palmer, K., Kivipelto, M., Jelic, V., Fratiglioni, L.,

Wahlund, L.O. “Mild cognitive impairment--beyond

controversies, towards a consensus: report of the International

Working Group on Mild Cognitive Impairment”, Journal of

Internal Medicine, Vol. 256, No. 3, pp. 240-246, 2004.

222. Wolf-Maier, K., Cooper, R.S., Banegas, J.R., Giampaoli, S.,

Hense, H.W. and Joffres, M. “Hypertension prevalence and blood

pressure levels in European countries, Canada, and the United

States”, Journal of the American Medical Association, Vol. 289,

No. 18, pp. 2363-2369, 2003.

223. World Health Organization “WHO study group on diabetes

mellitus. Technical Report. Series 727, Geneva”, World Health

Organization, 1985.

199

224. Worrall, G., Moulton, N. and Briffett, E. “Effect of type II

diabetes mellitus on cognitive function”, The Journal of Family

Practice, Vol. 36, pp. 639-643, 1993.

225. Yaffe, K., Barnes, D., Nevitt, M., Lui, L.Y., Covinsky, K. “A

prospective study of physical activity and cognitive decline in

elderly women: women who walk”, Archives of Internal

Medicine, Vol. 161, pp. 1703-1708, 2001.

226. Yeung, Sophie E., Fischer, Ashley L., Dixon and Roger, A.

“Exploring Effects of Type 2 Diabetes on Cognitive Functioning

in Older Adults”, Neuropsychology, Vol. 23, No. 1, pp. 1, 2009.

227. Young, C.M. and Trulson, M.F. “Methodology for dietary studies

in epidemiological survey s.II. Strengths and weaknesses in

existing methods”, American Journal of Public Health, Vol. 50,

pp. 803-814, 1960.

228. Zimmet, P., Alberti, K.G. and Shaw, J. “Global and societal

implications of thediabetes epidemic”, Nature, Vol. 414,

No. 6865, pp. 782-787, 2001.

229. Zola-Morgan, S. and Squire, L.R. “Neuroanatomy of memory”,

Annual Review of Neuroscience, Vol. 16, pp. 547-563, 1993.